Oryzon Genomics (STU:ORN) EPS (Basic) : €-0.05 (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Oryzon Genomics EPS (Basic)?

Oryzon Genomics's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was €-0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.05.

Oryzon Genomics's EPS (Diluted) for the three months ended in Mar. 2024 was €-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.05.

Oryzon Genomics's EPS without NRI for the three months ended in Mar. 2024 was €-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was -0.05.

During the past 3 years, the average EPS without NRI Growth Rate was 3.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was -9.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Oryzon Genomics's highest 3-Year average EPS without NRI Growth Rate was 25.50% per year. The lowest was -42.10% per year. And the median was 3.55% per year.

Oryzon Genomics EPS (Basic) Historical Data

The historical data trend for Oryzon Genomics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oryzon Genomics EPS (Basic) Chart

Oryzon Genomics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-0.08

-0.07

-0.09

-0.08

-0.06

Oryzon Genomics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial															-0.03	0.02	-0.02	-0.03	-0.02

Oryzon Genomics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Oryzon Genomics's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-3.398	-	0)	/	60.879
	=	-0.06

Oryzon Genomics's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.14	-	0)	/	61.216
	=	-0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.05

Oryzon Genomics (STU:ORN) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Oryzon Genomics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Oryzon Genomics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Oryzon Genomics (STU:ORN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (STU:ORN) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

ORYZF:USA ORY:Spain

Address

Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940

Website

http://www.oryzon.com

Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.